Preferential integration of a transfected marker gene into spontaneously expressed fragile sites of a breast cancer cell line

Cancer Letters

Volumn 189, Issue 2, 2003, Pages 207-219

  Matzner, Isabel ^a   Savelyeva, Larissa ^a   Schwab, Manfred ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Breast cancer; Chromosome; Common fragile sites; Fluorescent in situ hybridization; Genome analysis; Insertional mutagenesis; Loss of heterozygosity; Recombination

Indexed keywords

DNA; NEOMYCIN;

ARTICLE; BREAST CANCER; CELL LINE; CONTROLLED STUDY; DRUG RESISTANCE; FLUORESCENCE; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC TRANSFECTION; GENOME; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; MARKER GENE; MOLECULAR CLONING; PRIORITY JOURNAL;

ADENOCARCINOMA; BREAST NEOPLASMS; CHROMOSOME FRAGILE SITES; CHROMOSOME FRAGILITY; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN; DNA REPAIR; DNA, NEOPLASM; FEMALE; GENES, REPORTER; GENES, TUMOR SUPPRESSOR; GENETIC VECTORS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KANAMYCIN KINASE; KARYOTYPING; MUTAGENESIS, INSERTIONAL; RECOMBINANT PROTEINS; RECOMBINATION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED; VIRUS INTEGRATION;

INSERTION SEQUENCES;

EID: 0037469080     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(02)00504-9     Document Type: Article

References (31)

1. Dekaban A. Persisting clone of cells with an abnormal chromosome in a woman previously irradiated. J. Nucl. Med. 6:1965;740-746.
2. Glover T.W. Instability at chromosomal fragile sites. Recent Results Cancer Res. 154:1998;185-199.
3. Sutherland G.R., Baker E., Richards R.I. Fragile sites still breaking. Trends Genet. 14:1998;501-506.
4. Berger R., Bloomfield C.D., Sutherland G.R. Report of the Committee on Chromosome Rearrangements in Neoplasia and on Fragile Sites. Cytogenet. Cell Genet. 40:1985;490-535.
5. Warren S.T. The expanding world of trinucleotide repeats. Science. 271:1996;1374-1375.
6. Sutherland G.R., Richards R.I. The molecular basis of fragile sites in human chromosomes. Curr. Opin. Genet. Dev. 5:1995;323-327.
7. Glover T.W., Berger C., Coyle J., Echo B. DNA polymerase alpha inhibition by aphidicolin induces gaps and breaks at common fragile sites in human chromosomes. Hum. Genet. 67:1984;136-142.
8. Ban S., Cologne J.B., Neriishi K. Effect of radiation and cigarette smoking on expression of FUdR- inducible common fragile sites in human peripheral lymphocytes. Mutat. Res. 334:1995;197-203.
9. Huebner K., Garrison P.N., Barnes L.D., Croce C.M. The role of the FHIT/FRA3B locus in cancer. Annu. Rev. Genet. 32:1998;7-31.
10. Huebner K., Croce C.M. FRA3B and other common fragile sites: the weakest links. Nat. Rev. Cancer. 1:2001;214-221.
11. Glover T.W., Stein C.K. Chromosome breakage and recombination at fragile sites. Am. J. Hum. Genet. 43:1988;265-273.
12. Coquelle A., Pipiras E., Toledo F., Buttin G., Debatisse M. Expression of fragile sites triggers intrachromosomal mammalian gene amplification and sets boundaries to early amplicons. Cell. 89:1997;215-225.
13. Hellman A., Zlotorynski E., Scherer S.W., Cheung J., Vincent J.B., Smith D.I., Trakhtenbrot L., Kerem B. A role for common fragile site induction in amplification of human oncogenes. Cancer Cell. 1:2002;8997.
14. Hecht F. Enigmatic fragile sites on human chromosomes. Trends Genet. 4:1988;121-122.
15. Yunis J.J., Soreng A.L., Bowe A.E. Fragile sites are targets of diverse mutagens and carcinogens. Oncogene. 1:1987;59-69.
16. Popescu N.C., Zimonjic D., DiPaolo J.A. Viral integration, fragile sites, and proto-oncogenes in human neoplasia. Hum. Genet. 84:1990;383-386.
17. Rassool F.V., McKeithan T.W., Neilly M.E., van Melle E., Espinosa R. 3rd, Le Beau M.M. Preferential integration of marker DNA into the chromosomal fragile site at 3p14: an approach to cloning fragile sites. Proc. Natl. Acad. Sci. USA. 88:1991;6657-6661.
18. Rassool F.V., Le Beau M.M., Shen M.L., Neilly M.E., Espinosa R. 3rd, Ong S.T., Boldog F., Drabkin H., McCarroll R., McKeithan T.W. Direct cloning of DNA sequences from the common fragile site region at chromosome band 3p14.2. Genomics. 35:1996;109-117.
19. Palin A.H., Critcher R., Fitzgerald D.J., Anderson J.N., Farr C.J. Direct cloning and analysis of DNA sequences from a region of the Chinese hamster genome associated with aphidicolin-sensitive fragility. J. Cell Sci. 111:1998;1623-1634.
20. An H.X., Claas A., Savelyeva L., Seitz S., Schlag P., Scherneck S., Schwab M. Two regions of deletion in 9p23-24 in sporadic breast cancer. Cancer Res. 59:1999;3941-3943.
21. Savelyeva L., Claas A., Matzner I., Schlag P., Hofmann W., Scherneck S., Weber B., Schwab M. Constitutional genomic instability with inversions, duplications, and amplifications in 9p23-24 in BRCA2 mutation carriers. Cancer Res. 61:2001;5179-5185.
22. Schwab M., Claas A., Savelyeva L. BRCA2: a genetic risk factor for breast cancer. Cancer Lett. 175:2002;1-8.
23. Schwab M., Praml C., Amler L.C. Genomic instability in 1p and human malignancies. Genes Chromosomes Cancer. 16:1996;211-229.
24. Wang Z., Lai F.M., Zhang J. Analysis of loss of heterozygosity on chromosome 6 in human prostate carcinoma and prostatic intraepithelial neoplasia (in Chinese). Zhonghua Bing Li Xue Za Zhi. 30:2001;414-417.
25. Barghorn A., Speel E.J., Farspour B., Saremaslani P., Schmid S., Perren A., Roth J., Heitz P.U., Komminoth P. Putative tumor suppressor loci at 6q22 and 6q23-q24 are involved in the malignant progression of sporadic endocrine pancreatic tumors. Am. J. Pathol. 158:2001;1903-1911.
26. Singh B., Gogineni S.K., Sacks P.G., Shaha A.R., Shah J.P., Stoffel A., Rao P.H. Molecular cytogenetic characterization of head and neck squamous cell carcinoma and refinement of 3q amplification. Cancer Res. 61:2001;4506-4513.
27. Zweemer R.P., Ryan A., Snijders A.M., Hermsen M.A., Meijer G.A., Beller U., Menko F.H., Jacobs I.J., Baak J.P., Verheijen R.H., Kenemans P., van Diest P.J. Comparative genomic hybridization of microdissected familial ovarian carcinoma: two deleted regions on chromosome 15q not previously identified in sporadic ovarian carcinoma. Lab. Invest. 81:2001;1363-1370.
28. Bockmuhl U., Schluns K., Kuchler I., Petersen S., Petersen I. Genetic imbalances with impact on survival in head and neck cancer patients. Am. J. Pathol. 157:2000;369-375.
29. Cailleau R., Olive M., Cruciger Q.V.J. Long-term human breast carcinoma cell lines of metastatic origin: preliminary characterization. In Vitro. 14:1978;911-915.
30. Southern P.J., Berg P. Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J. Mol. Appl. Genet. 1:1982;327-341.
31. Collins C., Kuo W.L., Segraves R., Fuscoe J., Pinkel D., Gray J.W. Construction and characterization of plasmid libraries enriched in sequences from single human chromosomes. Genomics. 11:1991;997-1006.